Paul Maier

Paul Maier

Independent Director

Paul V Maier has over 35 years experience in the pharmaceutical industry including senior executive and board level positions with public biotechnology, specialty pharmaceutical and diagnostic companies from development stage through commercialization.

His most recent roles include Chief Financial Officer at Sequenom, Inc and Ligand Pharmaceuticals Inc. He currently serves on the Board of Directors and Audit Committee Chair of three other public companies and one private company. He is also Chairman of the Board of Lackey Clinic, a Free and Charitable Healthcare Center providing services to those without insurance. He is an Executive Partner at the College of William & Mary Mason School of Business.

Mr. Maier earned an MBA from Harvard Business School and a bachelor’s degree in Business Logistics from Pennsylvania State University.

About Small Pharma

We’re a mental health drug development company that’s accelerating the development of fast acting antidepressant treatments using DMT based therapies. We’re dedicated to making a difference.

With a focus on innovative approaches and committed to challenging the status quo, we’re targeting the root causes of depression and hoping to unlock the minds of millions.

Get Small Pharma updates

    Investor Deck

    Follow us: